project id: TCGA-KIRP; case submitter id: TCGA-A4-8312; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 8.2; age at index: 60; days to birth: -22231; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1952; age at diagnosis: 22231; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 708.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 38.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-A4-8312-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 85.0;